Released: Friday 5th March 2021

• MIJ Launched their second fund in the second half of 2020, with the UK the priority investment market for MIJ outside of Japan.
• MIJ partners with Bamburgh Capital to source investment opportunities in the UK, with a focus on introducing MIJ to pioneering companies across drug discovery, digital health, and medical devices.
• MIJ have already made two landmark investments from their second fund in early-stage life sciences businesses in the UK and are focused on building their investment pipeline to deploy further capital.
• With a deep science and commercial background, MIJ have quickly established themselves as a trusted partner and co-investor in the UK life sciences community. They also bring invaluable insight and capability to help companies access the Japanese market, the third-largest healthcare market globally.
• Interested parties should connect with Bamburgh Capital in the first instance - contact details are included in the press release and on the Bamburgh Capital website

For further details please click here.